Rainier Acquisition Holders Can Begin Separating SPAC Units Into Shares and Warrants

Rainier Acquisition Corporation holders can begin separating the SPAC’s publicly traded units into Class A ordinary shares and redeemable warrants starting September 14. The components are scheduled to begin trading separately on the Nasdaq Capital Market on September 15 under the symbols RNAQ for the shares and RNAQW for the warrants, while units that remain bundled will continue trading as RNAQU.

Each Rainier unit contains one Class A ordinary share and one-quarter of one redeemable warrant. A whole warrant entitles the holder to buy one Class A ordinary share for $11.50, subject to the adjustments set out in the warrant terms. Rainier will not issue fractional warrants when units are separated, and only whole warrants can trade or be exercised. In practical terms, four units are needed to produce one whole public warrant through a separation.

Rainier disclosed the timetable in a September 11 Form 8-K filed with the Securities and Exchange Commission. Holders who want to separate their units must have their brokers contact Continental Stock Transfer & Trust Company, Rainier’s transfer agent. The filing does not require every holder to split the units; investors can continue holding and trading RNAQU if they prefer the bundled security.

Separation changes how the securities trade

The separation is a change in how holders can own and trade the securities that were already packaged together in the IPO units. It is not a redemption from Rainier’s trust account and it does not by itself signal that the SPAC has selected an acquisition target. The September 11 filing is limited to the separate trading of the Class A shares and warrants.

The warrants also do not become immediately exercisable simply because they begin trading on their own. Rainier’s IPO prospectus says the public warrants become exercisable only at the later of one year after the offering closes or the completion of the company’s initial business combination, subject to the registration and other conditions in the warrant agreement. The warrants are scheduled to expire five years after an initial business combination, unless they are redeemed or the company is liquidated earlier.

That distinction matters because a separately quoted warrant can trade in the market before its holder is allowed to exercise it. Its value can therefore reflect expectations about Rainier’s future acquisition, the eventual value of the post-deal shares, the $11.50 exercise price and the remaining life of the warrant. Class A shares, meanwhile, carry the shareholder rights associated with the public shares and remain subject to the redemption framework described in Rainier’s SPAC documents.

Rainier raised $86.25 million after the over-allotment

Rainier’s units first began trading on Nasdaq on August 27. The SPAC initially sold 7.5 million units at $10 each, producing $75 million of gross proceeds before underwriting discounts and offering expenses. The underwriter then exercised its over-allotment option in full for another 1.125 million units, bringing the public offering to 8.625 million units and gross proceeds to $86.25 million.

Rainier said the full $86.25 million, equivalent to $10 for each public unit sold, was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company for the benefit of public shareholders. Chardan Capital Markets acted as the sole book-running manager. The trust structure is central to the SPAC model because public shareholders generally retain redemption rights tied to the cash held in trust when Rainier seeks shareholder approval for its initial business combination or if the company reaches its deadline without completing one.

The unit structure gives investors two different instruments once separation becomes available. The Class A share represents the public equity interest in the SPAC, while the warrant provides a contractual right to buy a share later if its exercise conditions are met. Keeping the RNAQU unit preserves both pieces in a single listed security. Separating the unit lets a holder sell or retain the share and warrant independently, subject to the whole-warrant requirement.

Rainier is searching for a life-sciences target

Rainier is a Cayman Islands blank-check company led by Chief Executive Officer Gbola Amusa and Chief Financial Officer Guy Barudin. In its IPO prospectus, the company said it plans to focus its search on global life sciences, including therapeutics, diagnostics, genomics, precision medicine, life science tools, research services and biomanufacturing, although it is not formally limited to those sectors or to a specific geography.

The company was incorporated in 2023 under the name Chardan Healthcare Acquisition 4 Company and adopted the Rainier Acquisition Corporation name in March 2026. Before the IPO, Rainier said it had not selected a specific business combination target and had not begun substantive discussions with one. The September 11 separation filing does not identify a target or announce a merger, acquisition or other deal.

Under the terms described in its prospectus, Rainier generally has 24 months from the closing of the IPO to complete an initial business combination, unless that period is changed through the procedures available to the company and its shareholders. If it does not complete a deal within the applicable period, the prospectus provides for the public shares to be redeemed from the trust account and for the company to wind down, subject to the terms and deductions described in the filing.

The immediate milestone is now the start of separate Nasdaq trading. Holders can elect to split their RNAQU units beginning September 14, but RNAQ shares and RNAQW warrants are scheduled to begin trading as standalone securities on September 15. Investors who take no action can continue holding the original RNAQU units.